TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Norovent AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
12,377
|
13,430
|
11,783 |
Financial expenses |
8
|
16
|
-1 |
Earnings before taxes |
867
|
859
|
1,098 |
Total assets |
4,790
|
4,647
|
3,937 |
Current assets |
3,151
|
2,815
|
2,523 |
Current liabilities |
1,862
|
2,796
|
2,567 |
Equity capital |
2,048
|
1,651
|
1,302 |
- share capital |
101
|
108
|
105 |
Employees (average) |
10
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
42.8%
|
35.5%
|
33.1% |
Turnover per employee |
1,343
|
982 | |
Profit as a percentage of turnover |
7.0%
|
6.4%
|
9.3% |
Return on assets (ROA) |
18.3%
|
18.8%
|
27.9% |
Current ratio |
169.2%
|
100.7%
|
98.3% |
Return on equity (ROE) |
42.3%
|
52.0%
|
84.3% |
Change turnover |
-164
|
1,282
|
-389 |
Change turnover % |
-1%
|
11%
|
-3% |
Chg. No. of employees |
-2
|
1 | |
Chg. No. of employees % |
-17%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.